Christopher Bulow founded Viosera Therapeutics, which developed antimicrobial drugs, and subsequently founded ResistanceBio to address drug resistance challenges in cancer treatment for pharmaceutical companies.
Intro paths
YC
Christopher went through Y Combinator (Winter 2019) — any YC alum in your network can reach them through the YC community.
→
In turn, Christopher can intro founders to ResistanceBio's investors below.
